ZTS

AS OF

Nov 20, 04:59 PM (EDT)

Price

$115.87

Change

-$1.21 (-1.03%)

Capitalization

51.07B

89 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ZTS

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

ZOETIS (ZTS) Ownership - Who owns ZOETIS?

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals... Show more

Industry: #Pharmaceuticals Generic

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Pharmaceuticals Generic

Address

10 Sylvan Way

Phone

+1 973 822-7000

Employees

14100

Web

https://www.zoetis.com

Details

Group

Domestic Stock Funds

Fundamentals

ZTS

Capitalization

51.1B

P/E Ratio

19.51

Risk (Beta)

1.03

Dividend Yield

0.02

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

6.79B

Total Debt/Equity

332.85

Projected Growth (PEG Ratio)

2.18

Revenue/Share (as % of the share price)

21.02%

Revenue

9.39B

ROE

N/A

Book Value

4.98B

P/B Ratio

9.46

Cash Flow

N/A

Earnings

5.81

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

1.76

Current Revenue Per Employee

178260.88

Dividends Per Share - Security

0.50

EBITDA

4.02B

Float

N/A

Float - Current

N/A

Gross Income Margin

73.62

Revenue To Assets

18.24

Shares Held By Institutions

134B

Shares Outstanding - Current

441M

Total Liabilities

9.5B

Total Volume MTD

N/A

Value

Gain YTD

-27.186

View a ticker or compare two or three

Compare

ZTS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ZTS showed earnings on November 04, 2025. You can read more about the earnings report here.

View AI-Driven Trading for ZTS

A.I. Advisor

published General Information

General Information

a pet medication company

Industry PharmaceuticalsGeneric